Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : May 10, 2019 06:30 PM IST | Source: PTI

Strides Pharma Science Q4 profit after tax at Rs 43.81 cr

The company's consolidated revenue from operations stood at Rs 3,011.68 crore for 2018-19, against Rs 2,845.12 crore in the year-ago period.

Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Strides Pharma Science May 10 reported a consolidated profit after tax of Rs 43.81 crore from operations for the March 2019 quarter. The company had posted a loss of Rs 3.39 crore in the year-ago period, the company said in a BSE filing.

Consolidated revenue stood at Rs 839.70 crore for the quarter under review as against Rs 669.89 crore for the same period a year ago.

For 2018-19, the company posted a profit after tax of Rs 58.93 crore compared to Rs 74.27 crore in 2017-18.

Close

The company's consolidated revenue from operations stood at Rs 3,011.68 crore for 2018-19, against Rs 2,845.12 crore in the year-ago period.

"Starting the year with several challenges, we are satisfied with our FY19 exit quarter performance as most of the strategic outcomes have met our expectations," Strides Pharma Science founder and group CEO Arun Kumar said.

Moving into the new financial year, company's emerging market and institutional business will get highest attention and priority, he added.

The company said its board has proposed a final dividend of Rs 3 per equity share of face value of Rs 10 each.

Shares of Strides Pharma Science closed at Rs 485.70 per scrip on the BSE, up 0.37 per cent from its previous close.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

First Published on May 10, 2019 06:10 pm
Sections
Follow us on